Skip to main content

Table 1 Patient cohort

From: MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

Clinical Variable All High-Grade
Serousa
Clear
Cell
Endometrioid Mucinous Low-Grade
Serousb
No. cases (% of total) 289 (100%) 176 (61%) 8 (3%) 22 (8%) 49 (17%) 34 (12%)
Median Age (years) 58.8 60.4 56.1 54.3 57.5 46.4
Benign 7 0 0 0 7 0
Borderline 61 0 0 22 32 27
Stage Ic 79 11 6 14 35 13
Stage II 16 7 0 4 1 4
Stage III 155 131 2 1 5 16
Stage IV 30 27 0 2 0 1
Grade 1d 22 0 N/A 8 7 7
Grade 2 85 78 N/A 5 2 0
Grade 3 106 98 N/A 7 1 0
Residual Disease ≤ 1 cme 151 84 1 9 34 23
Residual Disease >1 cm 137 91 7 13 15 11
Deceased 146 126 2 5 9 4
  1. aIncludes one tumour of mixed histology of which serous was the predominant type.
  2. bBorderline serous tumours are included in the low-grade serous column.
  3. cStaging information missing for 2 patients (no staging for benign tumours).
  4. dClear cell carcinomas were not graded.
  5. eResidual disease information missing for 1 patient.